期刊文献+

尾加压素Ⅱ及其受体在急性肾损伤大鼠肾组织中的表达 被引量:4

Expression of urotensin Ⅱ and its receptor in nephridial tissues of rats with acute renal damage
下载PDF
导出
摘要 目的:观察急性肾损伤大鼠肾组织中尾加压素Ⅱ(UⅡ)及其受体(GPR14)mRNA表达的变化。方法:雄性Wistar大鼠随机分为对照组(10只,灌服生理盐水)和模型组(30只)。模型组大鼠给予关木通水煎剂灌胃25 d,于第3、7、15和25 d分别处死5只,停药10 d后2组大鼠全部处死,留取肾脏,用于肾脏病理学和UⅡ、GPR14 mRNA的检测。结果:(1)给药3 d后HE染色可见局部肾小管上皮细胞变性、坏死和崩解,并随给药时间的延长逐渐加重,停药10 d后病变未见减轻反而加重。(2)与对照组比较,模型组UⅡmRNA在给药15 d后明显升高(P<0.05),25 d后更高(P<0.01),实验结束时最高;GPR14 mRNA在给药7 d后即明显增强(P<0.05),15 d后显著增强(P<0.01),此后随着实验时间的延长逐渐增强。结论:在关木通所致肾损伤中UⅡ及其受体基因表达明显增强,提示UⅡ在急性肾损伤的发生发展中可能有一定的病理作用。 AIM: To observe the mRNA expression of urotensin II(UII) and its receptor(G protein-coupled receptor 14,GPR14) in nephridial tissues of rats with acute renal damage.METHODS: Male Wistar rats were divided into 2 groups: the rats in control group(n=10) were administered with normal saline by gavage;the rats in model group(n=30) were administered with Caulis Aristolochiae manshuriensis(CAM) by gavage for 25 d to induce acute renal damage.Every 5 rats in model group were sacrificed on the 3rd,7th,15th and 25th days during CAM treatment and all rats in the 2 groups were killed 10 d after withdraw of CAM.The kidneys were collected for pathological observation and the UII and GPR14 mRNA examination.RESULTS: The degeneration,necrosis and disintegration in tubules were observed as major pathological changes in the rat kidneys after 3 d of CAM administration.The pathological changes were aggravated following the duration of in CAM administration,and were remained and even worsen when CAM was withdrawn for 10 d.Compared with control group,the mRNA expression of UII was significantly elevated(P0.05) at the time point of CAM administration for 15 d,even obviously increased(P0.01) at the time point of CAM administration for 25 d,and remained at the highest levels to the end of the observation.The mRNA expression of GPR14 was significantly increased(P0.05) at the time point of CAM administration for 7 d,became higher(P0.01) on the 15th day,and gradually increased as the experimental time went on.CONCLUSION: The mRNA levels of UII and its receptor are significantly elevated in CAM-induced renal lesion in rats,suggesting that UII plays a pathological role in the development of acute renal damage.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2011年第7期1406-1408,共3页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.3057085)
关键词 尾加压素Ⅱ 急性肾损伤 Urotensin II Acute renal damage
  • 相关文献

参考文献7

  • 1陈素贤,罗萍,李才.尾加压素Ⅱ的非血流动力学作用及其在某些疾病中的意义[J].中国病理生理杂志,2007,23(8):1654-1657. 被引量:5
  • 2田琳,李才,赵岩,陈素贤,苗春生.尾加压素Ⅱ和转化生长因子β1在糖尿病大鼠肾脏的表达及其意义[J].吉林大学学报(医学版),2007,33(4):607-611. 被引量:4
  • 3Abdel-Razik AE,Forty EJ,Balment RJ,et al.Renalhaemodynamic and tubular actions of urotensinⅡin the rat. The Journal of Endocrinology . 2008
  • 4Mosenkis A,Kallem RR,Danoff TM,et al.Renal im-pairment,hypertension and plasma urotensin II. Nephrology Dialysis Transplantation . 2011
  • 5Takahashi K,Hirose T,Mori N,et al.The renin-angio-tensin system adrenomedulins and urotensinⅡin the kid-ney:possible renoprotection via the kidney peptide sys-tems. Peptides . 2009
  • 6Matsushita M,Shichiri M,Imai T,et al.Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. Journal of Hypertension . 2001
  • 7YM Sue,CH Chen,YH Hsu,CC Hou,CY Cheng,YC Chen,SL Lin,TW Chen,TH Chen.Urotensin II induces transactivation of the epidermal growth factor receptor via transient oxidation of SHP-2 in the rat renal tubular cell line NRK-52E. Growth Factors . 2009

二级参考文献38

  • 1王志坚,丁文惠,史力斌,孟磊,任自文,卜定方,张勇刚,唐朝枢.apoE基因敲除小鼠主动脉尾加压素Ⅱ受体GPR14表达的变化[J].中国病理生理杂志,2005,21(11):2081-2085. 被引量:3
  • 2李晓燕,翁孝刚.阿魏酸钠对实验性糖尿病大鼠肾脏的保护作用[J].郑州大学学报(医学版),2005,40(6):1079-1081. 被引量:2
  • 3吴小脉,范小芳,黄虹,骆健峰,毛孙忠,胡良冈,龚永生.一氧化氮对慢性缺氧高二氧化碳大鼠肺血管尾加压素Ⅱ的影响[J].中国病理生理杂志,2006,22(10):1905-1908. 被引量:2
  • 4Hassan GS,Douglas SA,Ohlstein EH,et al.Expression of urotensin-Ⅱ in human coronary atherosclerosis[J].Peptides,2005,26 (12):2464-2472.
  • 5Zhang AY,Chen YF,Zhang DX,et al.Urotensin Ⅱ is a nitric oxide -dependent vasodilator and natriuretic peptide in the rat kidney[J].Am J Physiol,2003,285 (4):F792-F798.
  • 6Watson AM,Lambert GW,Smith KJ,et al.Urotensin Ⅱ acts centrally to increase epinephrine and ACTH release and cause potent inotropin and chronotropic actions[J].Hypertension,2003,42 (3):373-379.
  • 7Totsune K,Takahashi K,Arihara Z,et al.Role of urotensin Ⅱ in patients on dialysis[J].Lancet,2001,358(9284):810 -811.
  • 8Totsune K,Takahashi K,Arihara Z,et al.Increased plasma urotensin Ⅱ levels in patients with diabetes mellitus[J].Clin Sci,2003,104(1):1 -5.
  • 9Totsune K,Takahashi K,Arihara Z,et al.Elevated plasma levels of immunoreactive urotensin Ⅱ and its increased urinary excretion in patients with type 2 diabetes mellitus:association with progress of diabetic nephropathy[J].Peptides,2004,25 (10):1809-1814.
  • 10Langham RG,Kelly DJ,Gow BM,et al.Increased expression of urotensin Ⅱ and urotensin Ⅱ receptor in human diabetic nephropathy[J].Am J Kidney Dis,2004,44(5):826 -831.

共引文献7

同被引文献40

  • 1陈志卫,胡永洲,吴好好,蒋惠娣.黄酮类化合物的合成及其血管舒张作用[J].药学学报,2005,40(11):1001-1007. 被引量:14
  • 2黄雯,陈薇.VEGF、bFGF和TGF-β_1在大鼠马兜铃酸肾损伤中的表达[J].首都医科大学学报,2006,27(5):643-646. 被引量:3
  • 3陈素贤,李才,苗春生,张秀云,范哲.尾加压素Ⅱ对大鼠肾小管上皮细胞的促丝裂作用[J].吉林大学学报(医学版),2007,33(2):204-206. 被引量:3
  • 4Matsushita M, Shichiri M, Lmai T, et al. Co-expression of uroten- sin II and its receptor(GPR14) in human cardiovascular and renal tissues[J]. J Hypertens, 2001,19(7) :2185-2190.
  • 5Tian L, Li C, Qi J, et al. Diabetes-induced upregulation of uroten- sin II and its receptor plays an important role in TGF-betal-mediated renal fibrosis and dysfunction [ J]. Am J Physiol Endocrinol Metab, 2008,295 (5) : 1234-1242.
  • 6Sue YM, Chen CH, Hsu YH, et al. Urotensin U induces transacliv-ation of the epidermal growth factor receptor via transient oxidation of SHP-2 in the rat renal tubular cell line NRK-52E[J]. Growth Fac- tots, 2009,27(3) :155-162.
  • 7Abde-Razik AE, Forty EJ, Balment RJ, et al. Renal haemody- namic and tubular actions of urotensin II in the rat[ J]. J Endocri- nol, 2008,198(3) :617-624.
  • 8Hursitoglu M, Tukek T, Cikrikcioglu MA, et al. Urotensin II lev- els in patients with chronic kidney disease and kidney transplants [J]. Ups J Med Sci, 2012,117(1) :22-27.
  • 9Takahashi K, Hirose T, Mori N, et al. The renin-angiotensin sys- tem adrenomedulins and urotensin II in the kidney : possible reno- protection via the kidney peptide systems [ J ]. Peptides, 2009,30 (8) :1575-1585.
  • 10谢先德.马兜铃酸致肾损害的特点及防治[J].传统医药,2006,15(11):55-56.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部